ClinConnect ClinConnect Logo
Search / Trial NCT06878287

Bright Light Therapy During Residential Alcohol Withdrawal

Launched by CENTRE HOSPITALIER ST ANNE · Mar 11, 2025

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called "Bright Light Therapy During Residential Alcohol Withdrawal," is looking at how effective light therapy is for people going through alcohol withdrawal. Researchers want to see if this special light treatment can help patients feel better during their recovery from alcohol use disorder. The trial is currently recruiting participants, and it is open to both men and women aged 18 to 65 years who have been diagnosed with alcohol use disorder and have been in treatment for at least two weeks.

To join the study, participants need to have experienced heavy drinking in the month before starting treatment and should be motivated to stop drinking alcohol. They should also be able to understand the study and give their consent. However, people with certain eye conditions, those who have received light therapy in the past six months, pregnant or breastfeeding women, and those with severe mental health issues or other substance use disorders cannot participate. If someone joins, they can expect to receive either the light therapy or a placebo (a treatment that looks and feels like the real thing but has no therapeutic effect) and will be monitored throughout the trial to see how they respond.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients must be aged from 18 to 65 years old and have a diagnosis of Alcohol Use Disorder
  • Patients must be intreated for alcohol withdrawal, for at least two weeks
  • Patients must report heavy drinking episodes in the past month
  • Patients must be able to understand medical information and consent to the treatment
  • Patients must be considering a goal of abstinence from alcohol
  • Exclusion Criteria:
  • Ophthalmic pathology (cataract, macular degeneration, glaucoma, retinitis pigmentosa) and diseases affecting the retina (retinopathy, diabetes, herpes, etc.)
  • Subjects who have already received light therapy in the last 6 months
  • Lactating of pregnant women
  • Psychiatric comorbidity requiring an intreatment, or risk of manic episode (subjects with depressive or anxious symptoms compatible with an out-treatment can be included)
  • Substance Use Disorder other than alcohol and/or tobacco
  • Severe cognitive impairment (MOCA \< 10)
  • Patients being under legal protection measure

About Centre Hospitalier St Anne

Centre Hospitalier St. Anne is a leading healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical research. With a strong emphasis on mental health and neurology, the center is committed to conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory guidelines. By fostering collaboration among multidisciplinary teams of experienced researchers and healthcare professionals, Centre Hospitalier St. Anne aims to contribute to the development of new therapies and treatment modalities, ultimately enhancing the quality of care for patients in both local and global contexts.

Locations

Paris, île De France, France

Paris, , France

Patients applied

0 patients applied

Trial Officials

Pierre Alexis GEOFFROY, PhD

Principal Investigator

University Hospital Group for Psychiatry and Neurosciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported